Cargando…
2-Bromoterguride–a potential atypical antipsychotic drug without metabolic effects in rats
RATIONALE: Recently, we showed that 2-bromoterguride acted as a dopamine D(2) receptor partial agonist, a serotonin 5-HT(2A) and α(2C)-adrenergic receptor antagonist, and exhibited antidopaminergic efficacy in amphetamine-induced locomotion (AIL) in rats without inducing catalepsy. OBJECTIVE: To ext...
Autores principales: | Franke, Robert T., Tarland, Emilia, Fink, Heidrun, Pertz, Heinz H., Brosda, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933731/ https://www.ncbi.nlm.nih.gov/pubmed/27317020 http://dx.doi.org/10.1007/s00213-016-4356-0 |
Ejemplares similares
-
Effects of 2-bromoterguride, a dopamine D(2) receptor partial agonist, on cognitive dysfunction and social aversion in rats
por: Tarland, Emilia, et al.
Publicado: (2017) -
Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat
por: Jassim, Goran, et al.
Publicado: (2011) -
Food Deprivation, Body Weight Loss and Anxiety-Related Behavior in Rats
por: Dietze, Silke, et al.
Publicado: (2016) -
Post-drug consequences of chronic atypical antipsychotic drug administration on the ability to adjust behavior based on feedback in young monkeys
por: Mandell, Dorothy J., et al.
Publicado: (2011) -
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
por: Gilca, Marilena, et al.
Publicado: (2014)